Occurrence and recurrence of hepatocellular carcinoma in patients with HCV genotype 1b related cirrhosis treated with Ledipasvir + Sofosbuvir ± Ribavirin

J Gastrointestin Liver Dis. 2020 Dec 13;29(4):690-691. doi: 10.15403/jgld-3148.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Benzimidazoles / therapeutic use*
  • Carcinoma, Hepatocellular / epidemiology*
  • Carcinoma, Hepatocellular / pathology
  • Carcinoma, Hepatocellular / virology
  • Fluorenes / therapeutic use*
  • Hepacivirus
  • Hepatitis C / complications
  • Hepatitis C / drug therapy*
  • Hepatitis C / pathology
  • Humans
  • Liver Cirrhosis / drug therapy
  • Liver Cirrhosis / pathology
  • Liver Cirrhosis / virology
  • Liver Neoplasms / epidemiology*
  • Liver Neoplasms / pathology
  • Liver Neoplasms / virology
  • Neoplasm Recurrence, Local / epidemiology
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / virology
  • Retrospective Studies
  • Ribavirin / therapeutic use*
  • Sofosbuvir / therapeutic use*

Substances

  • Antiviral Agents
  • Benzimidazoles
  • Fluorenes
  • ledipasvir, sofosbuvir drug combination
  • Ribavirin
  • Sofosbuvir